Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study
NCT: NCT06649955 · RECRUITING
Brief Summary
Following completion of the ALS Early Feasibility Study of the MyoRegulator® device for treatment of ALS (NCT06165172), the CALM study will further assess the feasibility of the MyoRegulator® device to treat ALS in an expanded number of individuals with ALS. CALM will gather additional preliminary evidence of clinical safety and potential effectiveness in this patient population with a longer follow-up period and additional secondary endpoints in a single-arm study prior to commencing a larger sham-controlled pivotal trial.
Frequently Asked Questions
What is Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study?
Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study is a clinical trial registered under NCT06649955. Current status: RECRUITING.
What is the status of NCT06649955?
The current status of NCT06649955 (Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study) is: RECRUITING.
When did Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study start?
Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study started on 2025-02-10.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.